Paraptosis

Beyond Apoptosis: Cellular Outcomes of Cancer Therapy

Volumn , Issue , 2008, Pages 157-174

  Sperandio, Sabina ^a   De Belle, Ian ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78649765988     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (80)

1. Clarke PGH, Clarke S. Nineteenth century research on naturally occurring cell death and related phenomena. Anat Embryol (Berl) 1996; 193:81-99.
2. Vogt C. Untersuchungen uber die Entwicjlungsgeschichte der geburtschelerkroete (Alytes obstetrician), p130, Solothum. Jent und Gassman. 1842.
3. Lockshin RA. The early modern period in cell death. Cell Death Differ 1997; 4:347-351.
4. Clarke PG. Developmental cell death: morphological diversity and multiple mechanisms. Anat Embryol 1990; 181(3):195-213.
5. Lockshin RA, Williams CM. Programmed cell death. I. Cytology of degeneration in the intersegmental muscles of the Pernyi silkmoth. J Insect Physiol 1965; 11:123.
6. Tata JR. Requirement for RNA and protein synthesis for induced regression of the tadpole tail in organ culture. Dev Biol 1966; 13(1):77-94.
7. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26(4):239-257.
8. Kerr JFR, Harmon B, Searle J. An electron microscope study of cell deletion in the anuran tadpole tail during spontaneous metamorphosis with special reference to apoptosis of striatal muscle fibres. J Cell Sci 1974; 14:571-585.
9. Wyllie AH, Kerr JFR, Currie AR. Cell death in the normal neonatal rat adrenal cortex. J Pathol 1973; 111:225.
10. Hewish DR, Burgoyne LA. Chromatin sub-structure. The digestion of chromatin DNA at regularly spaced sites by a nuclear deoxyribonuclease. Biochem Biophys Res Commun 1973; 52(2):504-510.
11. Williams JR, Little JB, Shipley WU. Association of mammalian cell death with a specific endonucleolytic degradation of DNA. Nature 1974; 252(5485):754-755.
12. Wyllie AH. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 1980; 284(5756):555-556.
13. Vaux DL, Cory S, Adams JM. bcl-2 gene promotes haemopoietic cell survival and co-operates with c-myc to immortalise pre-B cells. Nature 1988; 335:440-442.
14. Hengartner MO, Ellis RE, Horvitz HR. Caenorhabditis elegans gene ced-9 protects cells from programmed cell death. Nature 1992; 356(6369):494-499.
15. Horvitz HR, Ellis HM, Sternberg PW. Programmed cell death in nematode development. Neurosci Comment 1982; 1:56-65.
16. Yuan JY, Horvitz HR. The Caenorhabditis elegans genes ced-3 and ced-4 act cell autonomously to cause programmed cell death. Dev Biol 1990; 138(1):33-41.
17. Reed JC. Apoptosis-based therapies. Nat Rev/Drug Discov 2002; 1:111-121.
18. Reed JC. Apoptosis-targeted therapies for cancer. Cancer Cell 2003; 3:17-22.
19. Bredesen DE, Rao RV, Mehlen P. Cell death in the nervous system. Nature 2006; 443:796-802.
20. Leist M, Jaattela M. Four deaths and a funeral: from caspases to alternative mechanisms. Nat Rev Mol Cell Biol 2001; 2:1-10.
21. Roach HI, Aigner T, Kourai JB. Chondroptosis: a variant of apoptotic cell death in chondrocytes? Apoptosis 2004; 9:265-277.
22. Schweichel JU, Merker HJ. The morphology of various types of cell death in prenatal tissues. Teratology 1973; 7(3):253-266.
23. Sperandio S, De Belle I, Bredesen DE. An alternative, non-apoptotic form of programmed cell death. Proc Natl Acad Sci U S A 2000; 97(26):14376-14381.
24. Liu Y, Lehar S, Corvi C, et al. Expression of the insulin-like growth factor I receptor C terminus as a myristylated protein leads to induction of apoptosis in tumor cells. Cancer Res 1998; 58(3):570-576.
25. Bredesen DE, Mehlen P, Rabizadeh S. Receptors that mediate cellular dependence. Cell Death Differ 2005; 12:1031-1043.
26. Mazelin L, Bernet A, Bonod-Bidaud C, et al. Netrin-1 controls colorectal tumorigenesis by regulating apoptosis. Nature 2004; 431:80-84.
27. Castro-Obregon S, Del Rio G, Chen SF, et al. A ligand-receptor pair that triggers a non-apoptotic form of programmed cell death. Cell Death Differ 2002; 9:807-817.
28. Wang Y, Li X, Wang L, et al. An alternative form of paraptosis-like cell death, triggered by TAJ/TROY and enhanced by PDCD5 overexpression. J Cell Sci 2004; 117:1525-1532.
29. Schneider D, Gerhardt E, Bock J, et al. Intracellular acidification by inhibition of the Na+/H+-exchanger leads to caspase-independent death of cerebellar granule neurons resembling paraptosis. Cell Death Differ 2004; 11:760-770.
30. Chen Y, Douglass T, Jeffes EW, et al. Living T9 glioma cells expressing membrane macrophage colony-stimulating factor produce immediate tumor destruction by polymorphonuclear leukocytes and macrophages via a “paraptosis”-induced pathway that promotes systemic immunity against intracranial T9 gliomas. Blood 2002; 100(4):1373-1380.
31. Jadus MR, Chen Y, Boldaji MT, et al. Human U251MG glioma cells expressing the membrane form of macrophage colony-stimulating factor (mM-CSF) are killed by human monocytes in vitro and are rejected within immunodeficient mice via paraptosis that is associated with increased expression of three different heat shock proteins. Cancer Gene Ther 2003; 10(5):411-420.
32. Jambrina E, Alonso R, Alcade M, et al. Calcium influx through receptor-operated channel induces mitochondria-triggered parpatotic cell death. J Biol Chem 2003; 278:14134-14145.
33. Fombonne J, Padron L, Enjalbert A, et al. A novel paraptosis pathway involving LEI/L-DNaseII for EGF-induced cell death in somato-lactotrope pituitary cells. Apoptosis 2006; 11:367-375.
34. Fombonne J, Reix S, Rasolonjanahary R, et al. Epidermal growth factor triggers an original, caspase-independent pituitary cell death with heterogeneous phenotype. Mol Biol Cell 2004; 15:4938-4948.
35. Fischer U, Janicke RU, Schulze-Osthoff K. Many cuts to ruin: a comprehensive update of caspase substrates. Cell Death Differ 2003; 10:76-100.
36. Bursch W, Hochegger K, Torok L, et al. Autophagic and apoptotic types of programmed cell death exhibit different fates of cytoskeletal filaments. J Cell Sci 2000; 113:1189-1198.
37. Pilar G, Landmesser L. Ultrastructural differences during embryonic cell death in normal and peripherally deprived ciliary ganglia. J Cell Biol 1976; 68(2):339-356.
38. Cunningham TJ. Naturally occurring neuron death and its regulation by developing neural pathways. Int Rev Cytol 1982; 74:163-186.
39. Giordano DL, Murray M, Cunningham TJ. Naturally occurring neuron death in the optic layers of superior colliculus of the postnatal rat. J Neurocytol 1980; 9(5):603-614.
40. Cunningham TJ, Mohler IM, Giordano DL. Naturally occurring neuron death in the ganglion cell layer of the neonatal rat: morphology and evidence for regional correspondence with neuron death in superior colliculus. Brain Res 1981; 254(2):203-215.
41. Sohal GS, Weidman TA. Ultrastructural sequence of embryonic cell death in normal and peripherally deprived trachlear nucleus. Exp Neurol 1978; 61(1):53-64.
42. Chu-Wang IW, Oppenheim RW. Cell death of motoneurons in the chick embryo spinal cord. I. A light and electron microscopic study of naturally occurring and induced cell loss during development. J Comp Neurol 1978; 177(1):33-57.
43. Liu J-P, Baker J, Perkins AS, et al. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 1993; 75:59-72.
44. Cecconi F, Alvarez-Bolado G, Meyer BI, et al. Apaf1 (CED-4 homolog) regulates programmed cell death in mammalian development. Cell 1998; 94(6):727-737.
45. Hakem R, Hakem A, Duncan GS, et al. Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell 1998; 94(3):339-352.
46. Kuida K, Haydar TF, Kuan CY, et al. Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9. Cell 1998; 94(3):325-337.
47. Kuida K, Zheng TS, Na S, et al. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 1996; 384(6607):368-372.
48. Yoshida H, Kong YY, Yoshida R, et al. Apaf1 is required for mitochondrial pathways of apoptosis and brain development. Cell 1998; 94(6):739-750.
49. Chautan M, Chazal G, Cecconi F, et al. Interdigital cell death can occur through a necrotic and caspase- independent pathway. Curr Biol 1999; 9(17):967-970.
50. Oppenheim RW, Flavell RA, Vinsant S, et al. Programmed cell death of developing mammalian neurons after genetic deletion of caspases. J Neurosci 2001; 21(13):4752-4760.
51. Yaginuma H, Shiraiwa N, Shimada T, et al. Caspase activity is involved in, but is dispensable for, early motoneuron death in the chick embryo cervical spinal cord. Mol Cell Neurosci 2001; 18(2):168-182.
52. Franklin DJ, Berges JA. Mortality in cultures of the dinoflagellate Amphidinium carterae during culture senescence and darkness. Proc Biol Sci 2004; 271:2099-2107.
53. Dal Canto MC, Gurney ME. Development of central nervous system pathology in a murine transgenic model of human amyotrophic lateral sclerosis. Am J Pathol 1994; 145(6):1271-1279.
54. Turmaine M, Raza A, Mahal A, et al. Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington’s disease. Proc Natl Acad Sci U S A 2000; 97(14):8093-8097.
55. Regan RF, Panter SS, Witz A, et al. Ultrastructure of excitotoxic neuronal death in murine cortical culture. Brain Res 1995; 705(1-2):188-198.
56. Kang SJ, Sanchez I, Jing N, et al. Dissociation between neurodegeneration and caspase-11-mediated activation of caspase-1 and caspase-3 in a mouse model of amyotrophic lateral sclerosis. J Neurosci 2003; 23(13):5455-5460.
57. Kostic V, Jackson-Lewis V, de Bilbao F, et al. Bcl-2: prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis. Science 1997; 277(5325):559-562.
58. Li M, Ona VO, Guegan C, et al. Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model. Science 2000; 288(5464):335-339.
59. Sperandio S, Poksay K, De Belle I, et al. Paraptosis: mediation by MAP kinases and inhibition by AIP-1/Alix. Cell Death Differ 2004; 11:1066-1075.
60. Castro-Obregon S, Rao RV, del Rio G, et al. Alternative, nonapoptotic programmed cell death: mediation by arrestin 2, ERK2, and Nur77. J Biol Chem 2004; 279:17543-17553.
61. Allan LA, Morrice N, Brady S, et al. Inhibition of caspase-9 through phosphorylation at Thr 125 by ERK MAPK. Nat Cell Biol 2003; 5:647-654.
62. Chang L, Karin M. Mammalian MAP kinase signalling cascades. Nature 2001; 410:37-40.
63. Kulich SM, Chu CT. Sustained extracellular signal-regulated kinase activation by 6-hydroxydopamine: implications for Parkinson’s disease. J Neurochem 2001; 77(4):1058-1066.
64. Linford NJ, Yang Y, Cook DG, et al. Neuronal apoptosis resulting from high doses of the isoflavone genistein: role for calcium and p42/44 mitogen-activated protein kinase. J Pharmacol Exp Ther 2001; 299(1):67-75.
65. Mukherjee P, Pasinetti GM. Complement anaphylatoxin C5a neuroprotects through mitogen-activated protein kinase-dependent inhibition of caspase 3. J Neurochem 2001; 77(1):43-49.
66. Regan RF, Wang Y, Ma X, et al. Activation of extracellular signal-regulated kinases potentiates hemin toxicity in astrocyte cultures. J Neurochem 2001; 79(3):545-555.
67. Runden E, Seglen PO, Haug FM, et al. Regional selective neuronal degeneration after protein phosphatase inhibition in hippocampal slice cultures: evidence for a MAP kinase-dependent mechanism. J Neurosci 1998; 18(18):7296-7305.
68. Missotten M, Nichols A, Rieger K, et al. Alix, a novel mouse protein undergoing calcium-dependent interaction with the apoptosis-linked-gene 2 (ALG-2) protein. Cell Death Differ 1999; 6(2):124-129.
69. Vito P, Pellegrini L, Guiet C, et al. Cloning of AIP1, a novel protein that associates with the apoptosis-linked gene ALG-2 in a Ca2+-dependent reaction. J Biol Chem 1999; 274(3):1533-1540.
70. Wang X., Li N, Liu B, et al. A novel human phosphatidylethanolamine-binding protein resists tumor necrosis factor alpha-induced apoptosis by inhibiting mitogenactivated protein kinase pathway activation and phosphatidylethanolamine externalization. J Biol Chem 2004; 279:45855-45864.
71. LeRoith D, Roberts CTJ. The insulin-like growth factor system and cancer. Cancer Lett 2003; 195:127-137.
72. Plymate SR, Tennant M, Birnbaum RS, et al. The effect on the insulin-like growth factor system in human prostate epithelial cells of immortalization and transformation by simian virus-40 T antigen. J Clin Endocrinol Metab 1996; 81(10):3709-3716.
73. Tennant MK, Thrasher JB, Twomey PA, et al. Protein and messenger ribonucleic acid (mRNA) for the type 1 insulin-like growth factor (IGF) receptor is decreased and IGF-II mRNA is increased in human prostate carcinoma compared to benign prostate epithelium. J Clin Endocrinol Metab 1996; 81(10):3774-3782.
74. Plymate SR, Bae VL, Maddison L, et al. Reexpression of the type 1 insulin-like growth factor receptor inhibits the malignant phenotype of simian virus 40 T antigen immortalized human prostate epithelial cells. Endocrinology 1997; 138(4):1728-1735.
75. Plymate SS, Bae VL, Maddison L, et al. Type-1 insulin-like growth factor receptor reexpression in the malignant phenotype of SV40-T-immortalized human prostate epithelial cells enhances apoptosis. Endocrine 1997; 7(1):119-124.
76. Chott A, Sun Z, Morganstern D, et al. Tyrosine kinases expressed in vivo by human prostate cancer bone marrow metastases and loss of the type 1 insulin-like growth factor receptor. Am J Pathol 1999; 155:1271-1279.
77. Kaplan PJ, Mohan S, Cohen P, et al. The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model. Cancer Res 1999; 59(9):2203-2209.
78. Hongo A, Yumet G, Resnicoff M, et al. Inhibition of tumorigenesis and induction of apoptosis in human tumor cells by the stable expression of a myristylated COOH terminus of the insulin-like growth factor I receptor. Cancer Res 1998; 58(11):2477-2484.
79. Marzano C, Pellei M, Colavito D, et al. Synthesis, characterization, and in vitro antitumor properties of tris(hydroxymethyl)phosphine copper(I) complexes containing the new bis(1,2,4-triazol-1-yl)acetate ligand. J Med Chem 2006; 49:7317-7324.
80. Tardito S, Bussolati O, Gaccioli F, et al. Non-apoptotic programmed cell death induced by a copper(II) complex in human fibrosarcoma cells. Histochem Cell Biol 2006; 126:473-482.